Specialty Council on Oncology Pharmacy

2020 Members

Mimi Lo, PharmD, BCPS, BCOP {Chair}
Lo is a hematology/oncology clinical pharmacist at the UCSF Medical Center in San Francisco CA, where she specializes in hematology and adult stem cell transplantation. She also serves as an assistant clinical professor at the UCSF School of Pharmacy. Lo received her PharmD at Purdue University. She completed her PGY1 pharmacy practice residency and PGY2 oncology pharmacy residency at UW Medicine in Seattle, WA. Prior to her position at UCSF, Lo served as a hematology/oncology clinical pharmacy specialist at Rush University Medical Center in Chicago, IL.

Deborah Ward, PharmD, BCOP, BCPS {Vice Chair}
2015Psych_WardDr. Ward graduated with a Bachelor of Science degree in Chemistry from St Joseph’s University and worked for 5 years in the pharmaceutical industry as an Analytical Development Chemist. She then graduated from Temple University with a Bachelor of Science and Doctor of Pharmacy degrees. She completed an ASHP Accredited Residency in Pharmacy Practice at Shands Hospital at the University of Florida as well as a Hematology/Oncology Clinical Fellowship at Virginia Commonwealth University/Medical College of Virginia Hospitals in Richmond, Virginia. Dr Ward is a Clinical Pharmacy Specialist in Pediatric Oncology at St. Jude Children’s Research Hospital in Memphis, Tennessee.

Rabia S. Atayee, PharmD, BCPS
AtayeeAtayee is the Associate Dean for Admissions and Outreach and Associate Professor of Clinical Pharmacy at University of California San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) where she is actively involved in clinical, research, teaching, and external national activities with a focus in palliative care. She developed her role and the presence of a pharmacist on the palliative care team at UCSD Health System under a Collaborative Practice Protocol that has been approved and credentialed to practice under expanded scope of practice. Atayee graduated with a PharmD from University of California, San Francisco School of Pharmacy and went on to complete her residency in acute care at UCSD Medical Center. Atayee is the first pharmacist in Southern California to obtain a DEA license and has the authority to initiate controlled substances for the treatment of her palliative care patients. Her clinical expertise and excellence in patient care is exemplified by the growth of her clinical practice with her major research focus in palliative care with a minor research focus in the area of pharmacy education.

Sean P. Cosgriff, PharmD, BCOP 
2015Oncology_CosgriffCosgriff is Heme/Onc Clinical Pharmacy Specialist, VA Portland Health Care System Portland, Oregon. He graduated from Oregon State University with a Bachelor of Science degree in Pharmacy, and earned a Doctor of Pharmacy degree from Duquesne University. Cosgriff completed an oncology pharmacy specialty residency at the University of Pittsburgh Cancer Institute. He have been at the VA Portland Health Care System for 11 years and held adjunct faculty appointments at Oregon State University and Pacific University.

Thu Oanh Dang, PharmD, BCOP
Thu Oanh DangDang is a hematology/oncology clinical pharmacist at Massachusetts General Hospital (MGH) in Boston, MA since 2018. She is also a residency coordinator for PGY2 oncology at MGH and an adjunct professor at Massachusetts College of Pharmacy Health Sciences (MCPHS). Prior to MGH, Thu worked at Memorial Sloan Kettering CC as a lymphoma/MM specialist for eight years. Thu received her B.S. in biochemistry and PharmD degrees at the University of Washington. She completed PGY1 at the Franciscan Health System and PGY2 oncology pharmacy residency at University of Kansas MC.

Erik DeFreitas, PharmD, BCOP
Erik DeFreitasLieutenant Colonel DeFreitas is the Deputy Director of the U.S. Army Pharmacovigilance Center. He graduated with a Doctor of Pharmacy from Northeastern University. Completed an Oncology Pharmacy Residency at Walter Reed Army Medical Center and served as Chief of Oncology Pharmacy at Tripler Army Medical Center in Honolulu, HI. In addition, Erik received a MA in National Security from the Naval War College and MPH from Harvard University. He has held a variety of leadership positions within the Military Health System in California, Iraq, Hawaii and Washington DC. Erik continues to practice in Oncology Pharmacy at Fort Belvoir Community Hospital.

Jin Han, PharmD, PhD, BCPS

Jin is an Assistant Professor at College of Pharmacy, University of Illinois at Chicago (UIC) and a Clinical Pharmacist at the UIC Comprehensive Sickle Cell Center. He also co-directs the Personalized Medicine Program at UIC. Jin received his PhD degree from Baylor College of Medicine, and his PharmD degree from UIC. He completed PGY1 residency at Rush University Medical Center in Chicago. His areas of practice and research interest include sickle cell disease, pain management, pharmacogenomics, etc.

Cindy O’Bryant, PharmD, BCOP
O'BryantO’Bryant is a Professor with the Department of Clinical Pharmacy at the University of Colorado Skaggs School Pharmacy and Pharmaceutical Sciences and practices in the Developmental Therapeutics (Phase 1)/ GI/ Head & Neck cancer program where she is a principal investigator of Phase 1 clinical trials and organ dysfunction trials. She serves as director of the PGY2 Oncology Pharmacy Residency Program and Co-Director of the Oncology Clinical Research Fellowship. O’Bryant completed her PharmD at Mercer University and PGY2 Oncology Pharmacy residency at the University of Colorado Health Sciences Center.

Janelle B. Perkins, PharmD, BCOP
ONC_PerkinsPerkins is an Associate Professor in the Department of Pharmacotherapeutics and Clinical Research at the University of South Florida College of Pharmacy and practices in the Blood and Marrow Transplant (BMT) Clinic at Moffitt Cancer Center (MCC) in Tampa, Florida. She graduated from University of Florida with a BS Pharm and earned her PharmD from University of North Carolina and completed an oncology pharmacy residency at the VA Hospital in San Antonio, Texas. Prior to her current position, she was a faculty member in the BMT Program at MCC where she served as a principal investigator on clinical trials involving graft-versus-host disease and busulfan pharmacokinetics.